Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 2 studies
Add to Evidence TrackerResearch Summary
Analyzed using Evidence Intelligence™
Weight loss improves metabolic outcomes in obese patients with diabetes
Last updated July 22, 2026
Key finding
A significant but comparable reduction of IL-1β (p for difference = 0.56) was observed in both arms.
This study compared the effects of liraglutide and lifestyle counseling on metabolic outcomes in obese individuals with prediabetes or early type 2 diabetes, finding comparable improvements in key metrics.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Risk of bias
High Risk
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study compared the effects of liraglutide and lifestyle counseling on metabolic outcomes in obese individuals with prediabetes or early type 2 diabetes, finding comparable improvements in key metrics.
Clinical relevance
These findings are significant as they highlight the potential for lifestyle interventions to achieve similar metabolic benefits as pharmacological treatments in managing prediabetes and early type 2 diabetes. This could empower healthcare providers to recommend lifestyle changes confidently, knowing they can be effective alternatives or complements to medication.
Keep in mind
Unclear effectiveness of interventions due to lack of definitive effect sizes. Limited generalizability as the study focused on a specific population. Potential for unmeasured confounders affecting outcomes.
Published in
Journal Reference
Publication details and source links for this paper.
Paola GS, Sarah C, Rossella L, et al. Effects of liraglutide versus lifestyle changes on metabolic outcomes in obese subjects with prediabetes or early type 2 diabetes. Cardiovascular Diabetology. 2025;24:247. doi:10.1186/s12933-025-02706-8
Main Effects
IL-1β showed a significant but comparable reduction in both arms (p for difference = 0.56).
Glycaemic control improved comparably in both liraglutide and lifestyle counseling groups.
BMI decreased comparably in both treatment groups.
MASLD extent improved comparably in both arms.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Behavioral counseling, Liraglutide and BMI, Reduction in MASLD extent after weight loss, Reduction of IL-1β levels after weight loss, and 1 more.
This study contributes evidence to
Primary intervention
Behavioral counseling
Primary outcomes
- BMI
- Reduction in MASLD extent after weight loss
- Reduction of IL-1β levels after weight loss
Evidence topics
Primary intervention
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
8
Evidence pairs
8
Relationships
4
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
4
Related topics
8
Evidence pairs
310
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 8 evidence relationships
- Includes primary outcome data
- Linked to 4 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Add related evidence to your Evidence Tracker
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Diabetes Self-Management Education and Support (DSMES) Programs and Body Mass Index
Related evidence
Evidence relationship
GLP-1 Receptor Agonists and Body Mass Index
Save evidence
Evidence topic
Weight Loss
Save evidence
Core evidence
Study findings
The primary outcomes reported in this study.
Reduction in MASLD extent after weight loss
Behavioral counseling → Reduction in MASLD extent after weight loss
Behavioral counseling → Reduction in MASLD extent after weight loss
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerReduction of IL-1β levels after weight loss
Behavioral counseling → Reduction of IL-1β levels after weight loss
Behavioral counseling → Reduction of IL-1β levels after weight loss
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerTime to achieve glycaemic control with static protocol
Behavioral counseling → Time to achieve glycaemic control with static protocol
Behavioral counseling → Time to achieve glycaemic control with static protocol
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 76
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 3 studies
Add to Evidence TrackerReduction in MASLD extent after weight loss
Liraglutide → Reduction in MASLD extent after weight loss
Liraglutide → Reduction in MASLD extent after weight loss
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerReduction of IL-1β levels after weight loss
Liraglutide → Reduction of IL-1β levels after weight loss
Liraglutide → Reduction of IL-1β levels after weight loss
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerTime to achieve glycaemic control with static protocol
Liraglutide → Time to achieve glycaemic control with static protocol
Liraglutide → Time to achieve glycaemic control with static protocol
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Evidence Suggest
- Both liraglutide and lifestyle counseling led to similar improvements in metabolic outcomes.
- IL-1β reduction was significant but not statistically different between groups.
- Glycaemic control and BMI improvements were comparable across both interventions.
Who this applies to
- Obese individuals with prediabetes or early type 2 diabetes.
- Adults seeking alternatives to pharmacological treatments for diabetes management.
Keep in Mind
- Results may not apply to populations outside the study's criteria.
- Effectiveness of lifestyle changes may vary among individuals.
- Further research is needed to confirm long-term outcomes and effectiveness.
Between the Lines
- Unclear effectiveness of interventions due to lack of definitive effect sizes.
- Limited generalizability as the study focused on a specific population.
- Potential for unmeasured confounders affecting outcomes.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on GLP-1 Receptor Agonists and Body Mass Index, Diabetes Self-Management Education and Support (DSMES) Programs and Body Mass Index.
Related evidence relationships
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Medications
GLP-1 Receptor Agonists → Body Mass Index
Medications
Evidence Intelligence™
- EvidenceScore™
- 76
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 3 studies
View evidenceBehavioral & Lifestyle
Diabetes Self-Management Education and Support (DSMES) Programs → Body Mass Index
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 2 studies
View evidenceIncluded in these evidence collections
Curated evidence collections and hubs this study is part of.
Body Mass Index Evidence Hub
All studies measuring Body Mass Index
3 studies
outcome_hubMeasures Body Mass Index as a key outcome.
GLP-1 Receptor Agonists Evidence Hub
All studies on GLP-1 Receptor Agonists
3 studies
intervention_hubContributes to GLP-1 Receptor Agonists evidence base.
Diabetes Self-Management Education and Support (DSMES) Programs Evidence Hub
All studies on Diabetes Self-Management Education and Support (DSMES) Programs
2 studies
intervention_hubContributes to Diabetes Self-Management Education and Support (DSMES) Programs evidence base.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Liraglutide and BMI
Intervention: LiraglutideOutcome: BMI
3 results
All studies on Behavioral counseling and BMI
Intervention: Behavioral counselingOutcome: BMI
2 results
All studies on Liraglutide
Intervention: Liraglutide
3 results
All studies on Behavioral counseling
Intervention: Behavioral counseling
2 results
All studies measuring BMI
Outcome: BMI
3 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Diabetes Self-Management Education and Support (DSMES) Programs affect body mass index?
Strong Evidence
Diabetes Self-Management Education and Support (DSMES) Programs may improve Body Mass Index.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
BMI
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Mixed | 1 study
Why this answer: This answer is based on 15 supporting studies with generally consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does GLP-1 Receptor Agonists affect body mass index?
Strong Evidence
GLP-1 Receptor Agonists may improve Body Mass Index.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
BMI
EvidenceScore™ Strong | EvidenceScore™ 75.9 | moderate positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on 15 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Behavioral counseling affect reduction in masld extent after weight loss?
Emerging Evidence
Behavioral counseling appears to improve Reduction in MASLD extent after weight loss.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Reduction in MASLD extent after weight loss
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Liraglutide affect reduction in masld extent after weight loss?
Emerging Evidence
Liraglutide appears to improve Reduction in MASLD extent after weight loss.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Reduction in MASLD extent after weight loss
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Liraglutide is well tolerated in diabetes patients undergoing hemodialysis.Liraglutide may reduce stroke recurrence in type 2 diabetes patientsCBT improves diabetes management in patients with metabolic syndromeLiraglutide 3 mg pathway improves weight loss.Liraglutide improves glycaemic control in adults with T2D
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.